We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 10.14-3.2%Jun 14 4:30 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: E_K_S12/20/2019 8:37:21 AM
   of 7055
Johnson & Johnson to acquire remainder of Verb Surgical
Dec. 20, 2019 6:59 AM ET|

On the heels of its successful collaboration with Alphabet's Verily Life Sciences, Johnson & Johnson (NYSE: JNJ) has agreed to acquire the remaining stake in robotics and data science venture Verb Surgical for an undisclosed sum. The transaction should close in H1 2020.

Verb was a joint venture formed between J&J unit Ethicon and Google Life Sciences in late 2015.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext